Biosimilar program reshapes FDA’s objectivityFebruary 11, 2016Ankylosing spondylitisPsoriatic ArthritisRheumatoid ArthritisSpondyloarthropathiesBusiness of Medicine
Biologic treatment in pregnancy requires balancing risksJanuary 20, 2016Ankylosing spondylitisPsoriatic ArthritisLupus & Connective Tissue DiseasesRheumatoid ArthritisSpondyloarthropathies